#Coronavirus

A List of COVID-19 Vaccines Soon To Be Available In India

Cipla Gets A Nod To Import Moderna Vaccine, newborn calf serum in covaxin, covid-19 vaccine death, uttar pradesh vaccine wastage, COVID-19 Vaccine list, COVID-19 Vaccines list, Vaccination in Pregnant Women, free COVID-19 vaccines ,vaccine registration, States with high Covid19 ,sputnik v in india, Covovax in India ,AstraZeneca Vaccine Effectiveness, Celebrities vaccinated ,COVID-19 vaccine registration ,COVID-19 vaccine cost ,10 Million vaccines administered, COVID-19 vaccine doses
COVID-19 Vaccine list: After VK Paul, a member of NITI Aayog said on Wednesday, May 12, that any vaccine that is approved by FDA and WHO can come to India, it has opened doors to many international vaccines to be rolled out for vaccination in the country. The government of India is trying to make available more and more vaccines to the Indian population and take forward the inoculation drive.

According to Paul, the import license will be granted to these vaccines within only 1-2 days.

COVID-19 Vaccines list: Here is a list of COVID-19 vaccines soon to be available in India:

ZyCoV-D

ZyCoV-D, a three-dose plasmid DNA COVID vaccine manufactured by the Ahmedabad-based pharmaceutical company Zydus Cadila, is most likely to be available in the market by June of this year. The vaccine is India’s second indigenously-developed COVID-19 vaccine after Bharat Biotech’s Covaxin.

The pharma company is expecting to submit the efficacy data to the Drugs Controller General of India (DCGI), the vaccine regulator, by end of May.

The managing director of Zydus Group told ThePrint in an interview that the vaccine trial is progressing well and they are eventually looking for its approval in June.

Sputnik V

NITI Aayog member VK Paul said on Thursday that the Russian vaccine Sputnik V, which is developed by the Gamaleya Research Institute of Epidemiology and Microbiology will hit the market next week. It will be the third vaccine that will be added to India’s inoculation drive. The two-dose vaccine is to be taken at a gap of three weeks, and its unique feature is that antigens in both of its doses are different, unlike other vaccines that are available at the time.

However, the claim that only one dose can protect from the virus, also known as ‘Sputnik Light’ is yet to be examined for its efficiency.
About Russia’s Sputnik Light Paul said, “In case of Sputnik Light, they (developers) are saying that the first dose is enough. We are examining this claim. We will go through its data and immunogenicity, and after that, we will see. Let more information come in.”

Biological E. Vaccine

Another India-made vaccine developed by Hyderabad-based company Biological E is most likely to roll out for inoculation in August this year. This would be the fourth vaccine available in the country, and the third Indian vaccine to be used for COVID-19 inoculation.

The pharma company, which is the largest manufacturer of tetanus vaccines and snake poison antidotes in the country, is undergoing third-phase trials for the vaccine and is waiting for it to get approved after the trials are finished.

Pfizer and Moderna

The centre said on Thursday that Pfizer and Moderna’s COVID-19 vaccines might become available in the country in the third quarter of this year. In a press briefing done by VK Paul, a member of NITI Aayog, he said that the Department of Biotechnology and the Ministry of External Affairs have been in touch with the makers of Pfizer, Moderna, and also Johnson and Johnson to them available in India.

He also added that the companies are working in their own way and would talk about vaccine availability in the third quarter of the year.